New Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended September 30, mainly on account of decline in total income.
The company had posted a net profit of Rs 119.83 crore in the corresponding period of the previous fiscal.
Total income declined by 9.44 percent to Rs 796.96 crore for the quarter under review against Rs 880.05 crore in the same period a year ago, Alembic Pharmaceuticals said in a BSE filing.
During the quarter, the company’s international formulations business revenue fell 25.56 percent to Rs 262 crore while US formulations business revenue fell 29.36 percent to Rs 190 crore.
Alembic Pharmaceuticals said its India formulations business grew 6 percent to Rs 385